The International Congress on Hyperthermic Oncology (ICHO) is a common event of the academic hyperthermia societies STM (Society for Thermal Medicine, North America), ESHO (European Society for Hyperthermic Oncology) and ASHO (Asian Society for Hyperthermic Oncology) and takes place every four years while each society organizes an annual meeting in its continent.

In December 2024, we delivered - together with our esteemed exclusive Korean partner BiomediSyn  - a heckel-HT3000 whole-body hyperthermia system to the BS General Hospital in Incheon / Korea.

The recent Annual Meeting of ESHO (European Society for Hyperthermic Oncology), November 6-8, 2024, showcased significant developments in hyperthermic oncology, with particular emphasis on combined treatment protocols and technical and clinical quality assurance.

Guy's Cancer Center at King's College London has initiated an important clinical trial investigating thermography-controlled wIRA superficial hyperthermia using the hydrosun®TWH1500 system. This prospective study examines the real-world implementation of thermotherapy in conjunction with standard palliative radiotherapy.